Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> VACCINE Latest News

FEB 25, 2013 - Yahoo! News

A Must Read - Share

Dynavax may have to repitch hepatitis B vaccine for smaller market

(Reuters) - Dynavax Technologies Inc may need to repitch its hepatitis B vaccine for a smaller patient population, after U.S. health regulators declined to approve the vaccine for adults - an estimated $700 million global market. The U.S. Food and Drug Administration said the safety data provided by the company was insufficient to support an approval of Heplisav - Dynavax's most advanced clinical candidate. The company said in a statement earlier on Monday that the FDA had indicated its willingness to discuss a more restricted use of the vaccine. ...

Tags: Dynavax may have to repitch hepatitis B vaccine for smaller market,  Vaccine Latest News